Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics: Chris Smith

NeoGenomics has appointed Chris Smith as CEO and a member of its board of directors effective Aug. 15. Concurrently, board chair and interim CEO Lynn Tetrault will resume her role as independent chair of the board while assisting in the transition of responsibilities.

Smith joins NeoGenomics after serving as CEO of Ortho Clinical Diagnostics from 2019 to May 2022, during which time the firm raised $1.45 billion in funding in an initial public offering. Prior to Ortho Clinical, Smith held key executive leadership positions at Cochlear Limited. He has also served as CEO in residence at global private equity firm Warburg Pincus and Global Group President at Gyrus Group, as well as in a variety of leadership roles at Abbott, KCI, Prism and Cardinal Health. He holds a BS from Texas A&M University.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.